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ABSTRACT Binary systems combining a transition metal complex and ascorbate have been proposed recently for catalytic
therapy of malignant tumors. The killing effect on tumor cells is achieved by production of free radicals in the course of
accelerated oxidation of ascorbate by dioxygen in the presence of transition metal complexes. Further progress in the
development of binary catalytic systems (BCSs) requires a special method for their investigation in cells and tissues, because
neither component of BCSs fluoresces. Here a resonance Raman confocal spectral imaging (RR CSI) technique was
introduced as a unique approach to monitor quantitatively the transition metal complexes within living cells. Intracellular
accumulation, localization, and retention of theraphthal (TP), a catalyst of the advanced TP/ascorbate BCS, were investigated
in A549 cells with the RR CSI technique. The cellular analysis was complemented with the detailed study of molecular
interactions of TP in solution and environmental factors affecting the RR spectrum of TP. TP does not penetrate into
membranes, it binds very weakly to DNA and RNA, but it readily forms complexes with proteins. Binding with Ca2 cations
and decreasing pH below 6 induce aggregation of TP. By analyzing RR spectra recorded from every point within a TP-treated
cell, three states of the agent were discriminated, namely, monomeric TP in polar environment, TP bound to proteins, and
aggregated TP. Their cytoplasmic and nuclear distributions were mapped at different stages of uptake and efflux. By
introducing organelle-selective fluorescent probes into drug-treated cells and measuring intracellular localization of both the
probe and the drug, compartmentation of TP was revealed. Cell growth suppression by the TP/ascorbate system was
measured, and probable molecular and organelle targets of radical damage were characterized.
INTRODUCTION
The continuous search for new approaches to the effective
treatment of cancer diseases recently resulted in the devel-
opment of binary catalytic systems (BCSs) (Kimoto et al.,
1983; Vol’pin et al., 1996, 1998; Belkov et al., 1996;
Bubnovskaya et al., 1998). Similar to x-ray therapy and
photodynamic therapy, an antitumor action of these systems
is related to the production of free radicals, which induce
oxidative degradation of molecules and organelles of cancer
cells. BCSs employ a transition-metal complex as a catalyst
and a second molecule as a substrate. Autooxidation of the
substrate produces reactive oxygen species. The catalyst
accelerates this process strongly. Selective accumulation of
BCS components within malignant cells and/or in tumor
tissue is a necessary prerequisite for intense radical attack
followed by tumor growth suppression and necrosis.
The first attempt at BCS development for anticancer
applications was reported by Kimoto et al. (1983). A killing
effect on tumor cells and an increase in the life span of mice
after inoculation of tumor cells were achieved with copper:
glycylglycylhistidine complex and ascorbate as a substrate.
Recently, several promising new BCSs were discovered. It
was found that a combination of cobalt or iron phthalocy-
anine and sodium ascorbate has high in vitro and in vivo
antitumor activity (Vol’pin et al., 1996; Belkov et al., 1996).
These BCSs have been patented as new agents for binary
catalytic therapy of malignant tumors (Vol’pin et al., 1995).
A combination of theraphthal (TP, cobalt (II) octa-4,5-
carboxyphthalocyanine) (Fig. 1) and ascorbate was ap-
proved for phase I of a clinical trial. Pronounced cytotoxic
activity was found also for BCSs by employing complexes
of Co with vitamin B12 and its derivatives (Vol’pin et al.,
1998) and complexes of Co with tetradentate Schiff bases
having an MN2O2 coordination center, where M is metal
(Bubnovskaya et al., 1998).
Ascorbate is currently considered the most suitable sub-
strate for BCS. It is known that some human tumors accu-
mulate ascorbate to a greater extent than do normal tissues
(Honegger et al.,1988). Ascorbate is easily oxidized by
oxygen in the presence of transition metal ions and produces
reactive oxygen species such as H2O2, O2
•, and OH
(Halliwell and Foyer, 1976). Moreover, some products of
ascorbate oxidation have considerable antitumor effects
themselves (Cameron et al., 1979; Pierson et al., 1985;
Poydock, 1991).
During the last few years there has been a gradual in-
crease in the knowledge of in vitro and in vivo antitumor
effects induced by various BCSs under different regimes of
treatment (Vol’pin et al., 1996, 1998; Syrkin et al., 1998;
Bubnovskaya et al., 1998). Biodistribution and retention of
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some catalysts employed in BCSs were characterized in
organs and tissues by the use of extractive and fractionative
analytical techniques. However, practically nothing is
known about the localization and distribution of transition
metal complexes in cells and tissue structures at the micro-
scopic level. The problem is that paramagnetic metals such
as Cu, Co, and Fe shorten the lifetime of the excited state of
the complex, making the dye nonfluorescent and nonpho-
toactive. As a result, nondestructive detection and in situ
investigation of transition metal complexes in living cells
and tissues are much more complicated compared to those
of fluorescent drugs.
Further progress in directed synthesis and the study of
new compounds with improved catalytic and pharmacolog-
ical characteristics requires comprehensive understanding
of the behavior of BCS components in living systems,
revealing the correlation between the chemical structure of
the catalyst and its localization within cells, and the prox-
imity of the drug to the critical targets of its action. The first
attempt to apply the confocal direct Raman imaging method
to investigation of the localization of some transition metal
complexes (including TP) within cells was reported else-
where (Arzhantsev et al., 1999). The present work is aimed
at introducing the resonance Raman (RR) confocal spectral
imaging (CSI) technique for the detection and study of
nonfluorescent transition-metal complexes in living cells.
The CSI technique is an advanced approach to quantita-
tive monitoring of anticancer drug localization within living
cells with three-dimensional (3D) micron resolution. The
method is based on recording in confocal mode and analysis
of the whole spectrum of the drug from each point inside the
cell. It provides an important advantage in comparison with
other imaging methods that measure integrated signal inten-
sity selected by either broad- or narrowband filters; with the
CSI technique all of the spectrum parameters are accessible
to analysis. Thus the CSI technique allows the main prin-
ciples of spectral analysis, which are widely used to study
molecular interactions in solution, to be transferred to the
cellular level. It provides a unique opportunity to identify
and to map intracellular molecular interactions of drugs. It
opens the way to the study and direct comparison of mo-
lecular interactions in solution and within living cells.
According to the CSI technique the creation of spectral
images is based on a decomposition procedure that is ap-
plied to a set of spectra measured from within the cell. Each
original spectrum is decomposed into a sum of reference
spectra with appropriate coefficients. The reference spectra
are attributed to different states and specific interactions of
the drug within cells. The reference spectra originate from a
set of characteristic spectra corresponding to possible mo-
lecular interactions and environmental effects observed for
the drug in solution. Two-dimensional (2D) maps of de-
composition coefficients (spectral images) describe subcel-
lular distribution of the drug and its complexes.
The CSI technique was initially developed for the inves-
tigation of fluorescent drugs (Sharonov et al., 1994a; Feo-
fanov et al., 1997a,b). In the present work its applicability to
the study of nonfluorescent drugs in living cells is demon-
strated for the first time. The molecule has to absorb in a
visible region to be detectable in cells with RR spectros-
copy. Although the resonance Raman CSI technique does
not provide sensitivity comparable to that of fluorescence
microscopy, it is the only approach allowing molecular
interactions and distribution of nonfluorescent drug to be
studied with 3D micron resolution in living cells.
The high informational content of Raman and RR spec-
troscopy has been duly demonstrated in investigations of
biological molecules and their supramolecular complexes,
as well as in a variety of biological and medical applications
(Clark and Hester, 1993). RR microspectroscopic studies of
chromophore-containing biological molecules in living cells
have been reviewed recently (Greve and Puppels, 1993;
Puppels and Greve, 1996). Point measurements performed
in these cellular investigations were aimed at characterizing
structure and/or functional states of studied molecules in
particular cellular organelles or domains. To measure the
localization and continuous distribution of Raman scattering
species along microspecimens, several approaches to micro-
Raman image recording have been realized on a basis of
narrow-band interference filtering (Puppels et al., 1993;
Williams et al., 1994), tunable acoustooptic filtering
(Treado et al., 1992), Hadamard multiplexing (Treado and
Morris, 1990; Liu et al., 1991), and confocal scanning
(Sharonov et al., 1994b; Sijtsema et al., 1998) techniques.
The first three approaches are wide-field or global imaging
methods that allow the acquisition of Raman data on a
time-consuming point-by-point (or line-by-line) basis to be
avoided, but at the expense of the absence of axial resolu-
tion. The filtering methods employ a 2D camera to record
FIGURE 1 Structure of theraphthal (TP).
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Raman scattering from the specimen area illuminated by a
defocused laser beam. The spectral range to be detected is
selected in this case with the filter, and it can be as narrow
as 20 cm1 (Greve and Puppels, 1993; Puppels and Greve,
1996). The filtering method can also be realized on the basis
of the point-by-point (or line-by-line) confocal scanning of
the sample with the focused laser beam to provide the 3D
resolution (Sijtsema et al., 1998). The filtering techniques
are the most useful in the applications where 2D mapping of
a specimen can be made using the a priori known spectral
markers. In a more general case an extensive preliminary
Raman microspectroscopy examination of the sample is
required to identify spectral bands that are best suited for
recording the Raman images. Just a few applications of
Raman imaging techniques to the study of living cells have
been published up to date (Greve and Puppels, 1993; Sijt-
sema et al., 1998; Arzhantsev et al., 1999). They have been
concerned with the intracellular distribution of chro-
mophore-containing molecules.
In the present work the CSI approach was realized on the
basis of RR spectroscopy for the investigation of TP within
living cells. The combination of TP with ascorbate is one of
the most advanced BCSs (Syrkin et al., 1998). As a neces-
sary step to a deep understanding of mechanisms of cell
killing and critical cellular targets, the molecular interac-
tions of TP and its intracellular accumulation, localization,
and retention were investigated. Compartmentation of TP
was studied by introducing organelle-selective fluorescent
probes into drug-treated cells and measuring the intracellu-
lar distribution of both the probe and the drug. Cell growth
suppression with this BCS was also measured. The influ-
ence of radical attack on the cellular organelles was exam-
ined by the use of selective fluorescent probes.
MATERIALS AND METHODS
Chemicals
TP was received from NIOPIK (Moscow, Russia). A stock solution of TP
(1 mM) was prepared in phosphate-buffered saline (PBS) for cellular
experiments and in 20 mM Tris-HCl buffer (pH 7.4) for measurements in
solution. The concentration of TP in aqueous buffer solution was measured
by absorption, using an extinction coefficient 675  1  10
5 M1 cm1.
Calf thymus DNA, calf liver RNA, human and bovine serum albumins,
chicken egg white lysozyme, ethidium bromide (EtBr), and 3-[4,5-dimeth-
ylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) were purchased
from Sigma (St. Louis, MO). Gentamicine, L-glutamine, fetal calf serum,
and minimum essential medium (MEM)-Eagle culture medium were pur-
chased from MGIEM (Russia). Acridine orange (AO), rhodamine 123
(Rh123), and sodium ascorbate were purchased from ICN (Costa Mesa,
CA). All other chemicals used in this work were of analytical-reagent
grade.
An extract of nonhistone proteins from cell nuclei was a gift of Dr. L. G.
Nikolaev. The extraction was performed following a slightly modified
procedure described elsewhere (Dignam et al., 1983). Histone H2A was a
gift of Dr. V. L. Karpov.
Sample preparation for experiments in solution
Mixtures of TP with human (140 M) and bovine (140 M) serum
albumins, lysozyme (600 M), nonhistone proteins (10 mg/ml), histone
H2A (100 M), RNA (1.6 mM), and DNA (1.7 mM bp) were prepared in
buffer solution (20 mM Tris-HCl, pH 7.4). Detergent-containing solutions
of TP were prepared at the critical micelle concentration of Triton X-100
(t-octylphenoxypolyethoxyethanol, 0.24 mM) or sodium dodecyl sulfate
(8.27 mM) in buffer solution (20 mM Tris-HCl, pH 7.4). The solutions
were prepared at 2 and 50 M concentrations of TP for spectrophotometric
and microspectroscopic measurements, respectively.
Cells
A549 human lung adenocarcinoma cells were obtained from the Ivanovsky
Institute of Virology, Russian Academy of Medical Sciences. Cells were
cultured in 25 cm2 culture flasks at 37°C, 5% CO2 in MEM-Eagle culture
medium supplemented with 10% fetal calf serum inactivated with heating
and 0.03% L-glutamine. Cells were removed from flask walls with 25 mM
EDTA.
Cell treatment
For survival assays cells were seeded in 96-well plates (Costar) at 5  104
cells/ml and incubated for 24 h in culture medium. Stock solutions of TP
(1 mM) and sodium ascorbate (300 mM) were prepared in PBS. TP was
added gradually into wells to achieve final concentrations from 3 to 100
M in approximately twofold increments. Ascorbate was introduced 15
min later at a TP/ascorbate molar ratio of 1:20. Cells were incubated with
reagents for 48 h in a CO2 incubator, then inhibition of cell growth was
determined with an MTT test according to the procedure described else-
where (Carmichael et al., 1987).
For microscopic experiments cells were grown on coverglasses in wells
of 24-well plates (Costar) for 24 h. The sowing density was 5  104
cells/ml. To study drug uptake, cells were incubated with 100 or 400 M
of TP for 10 min or 1, 3, 6, or 14 h. To investigate drug efflux the cells were
treated with 400 M TP for 6 h, rinsed twice with warm (37°C) PBS
solution (pH 7.4), and incubated in TP-free culture medium for 2 or 9 h.
When cells were treated with TP/ascorbate mixture, sodium ascorbate (8
mM) was added to the medium 15 min after TP (400 M) was introduced.
Cells were incubated with the TP/ascorbate mixture for 3 or 6 h.
Selective labeling of cellular organelles was performed as follows. Cells
incubated with 100 M TP, TP/ascorbate mixture (100 M/2 mM), or 2
mM sodium ascorbate for 1 h or 3 h were rinsed twice with warm PBS
solution and treated for 10 min with 10 g/ml AO, 5 g/ml EtBr mixture,
or 10 g/ml Rh123. Then cells were rinsed twice with PBS solution. To
identify sites of TP localization, cells were incubated with 400 M TP for
2 h before staining with vital dyes.
For microscopic observations and measurements a glass with cells was
placed on a microscope slide and covered with a coverglass. To prevent
cells from drying during measurements, PBS solution (60 l) was intro-
duced under the coverglass.
Spectral measurements
Absorption spectra were measured with a Cary-209 spectrophotometer
(Varian, Sunnyvale, CA). To estimate an extent () of TP binding with
nucleic acids and proteins, the spectral decomposition of the absorption
spectrum of the TP/ligand mixture into the spectrum of the free drug and
another part, corresponding to a bound drug, was performed. The value of
 was calculated as follows:
  1 Cf/C0 100% (1)
Raman Imaging Study of Theraphthal 501
Biophysical Journal 78(1) 500–513
where C0 and Cf are, respectively, the total concentration of the drug and
the concentration of free drug in the TP/ligand mixture.
CSI measurements were performed using a V-45 installation (Dilor,
Lille, France) for scanning confocal microspectroscopy and imaging
(Favard et al., 1999). The Optiphot-2 microscope (Nikon, Japan) integrated
into this device was equipped with an epifluorescence unit. A sliding
mirror provided a choice between different regimes of specimen study:
observation of a cell in transmitted white light, or epifluorescent measure-
ments, or CSI measurements. The latter option was used in the present
study to make a microphotograph of the cell, to record a confocal spectral
image of TP distribution, and to observe the distribution of the selective
label of cellular organelles with the epifluorescence unit in the same cell.
Lateral and axial resolution in CSI measurements was 1 and 4 m,
respectively, when a 100 oil immersion objective was used. Spectral
resolution was 5 cm1. A motorized sample stage was used to provide a
point-by-point scanning regime. The 30  30 or 40  40 point spectral
images were recorded with 632.8-nm excitation wavelength of a He-Ne
laser (0.3 mW). The recording time for a 40 40 point spectral image was
15–20 min.
The procedures of spectrum treatment and spectral image creation were
described earlier (Sharonov et al., 1994a,b; Feofanov et al., 1995). Briefly,
each experimental spectrum recorded in confocal mode from within cells
was decomposed as a sum of reference spectra with appropriate coeffi-
cients. The reference spectra were carefully selected, based on the results
of model experiments in solution, to describe adequately different states of
the drug inside a cell (in this case monomers, aggregates, and complexes of
TP with proteins). The integrated intensity of each reference spectrum
multiplied by the decomposition coefficient for each point produced a 2D
map (hereafter referred to as the spectral image) that characterized the
relative distribution of monomers (aggregates, complexes with proteins) of
TP within the cell.
The calibration procedures have been performed to estimate subcellular
concentration of monomeric theraphthal (TPmono) and theraphthal bound to
proteins (TPbnd), based on the integral intensity of the corresponding
micro-Raman spectra. The spectra of TP and TP bound to proteins were
measured in aqueous buffer solution with a microscope under the experi-
mental conditions (optical pathway, geometry of light collection, lateral
and axial resolution, laser power, integration time) used for recording the
confocal spectral images. The calibration curves showed the linear depen-
dence of RR signal intensity on TP concentration. An inner filter effect
caused very little deviation from linearity, inasmuch as exciting and scat-
tered light passed the absorbing layer of 10–20 m only.
To quantify intracellular TP, a 2D set of the spectra measured from a
cell was decomposed into components corresponding to the set of reference
spectra, and RR intensities of the components corresponding to TPmono and
TPbnd were recalculated into concentrations based on results of the cali-
bration procedure. The amount of aggregated drug cannot be described in
terms of concentration. However, Raman intensity is proportional to the
amount of aggregates in each microvolume. Thus the relative quantity of
aggregates in different cellular compartments was compared based on the
intensity of the RR signal of the aggregated TP (TPagg) component. Such
a comparison was also performed for neighboring cells and for cells
incubated with the drug at different regimes. This was done while 1)
carefully maintaining the alignment of installation and keeping the exper-
imental conditions of measurements unchanged, 2) periodically checking
the intensity of the RR signal of reference TP solution in the course of
series of experiments.
All of the measurements have been repeated in two independent exper-
iments. Intracellular concentrations of TP were averaged over 20 cells for
each measurement. Standard deviations were 0.5–0.7 of average values.
These deviations were related to differences in the drug uptake by partic-
ular cells and were much more than errors of measurements and calcula-
tions (10–15%).
To measure RR cross sections of TP vibrational modes, the sample was
dissolved in a buffer (20 mM Tris-HCl, pH 7.4) that contained high-purity
sodium sulfate (0.5 M) as an internal standard of Raman intensity. RR
cross sections of TP vibrational modes were calculated according to the
equation
n sInCsIs1 Cn1 (2)
where the subscript index n shows that the parameter corresponds to the
vibrational mode of TP and s to the 981 cm1 band of the internal standard,
and n is the RR cross section for vibrational mode n at the 632.8-nm
excitation wavelength. I is the integral intensity of the Raman band. Cs and
Cn are the molar concentrations of sodium sulfate and TP, respectively.
The Raman cross section (s) of the 981 cm
1 sulfate vibrational mode at
632.8 nm excitation was calculated using the parameters estimated else-
where (Fodor et al., 1989) and found to be 1.6  1030 cm2 sr1
molecule1.
RR cross sections of vibrational modes of TP bound to protein were
calculated based on the known RR cross sections for free TP and taking
into account differences in intensity of the RR spectra of equimolar
solutions of TP in buffer solution and TP/protein complex that were
recorded under the same experimental conditions. It should be mentioned
that it was not possible to use sodium sulfate as an internal standard of
Raman intensity to measure RR cross sections of TP bound to protein,
because the high ionic strength of the solution affects considerably the
interactions of the drug with proteins.
RESULTS
Molecular interactions and environmental factors
affecting TP state in solution
Investigation of molecular interactions of TP in solution is
a necessary prerequisite for analysis of the drug in a cellular
environment. It helps one to understand the ability of TP to
bind to different cellular molecules and structures, thus
revealing probable intracellular complexes of the drug. The
knowledge of characteristic spectral changes induced by
environmental factors (pH, hydrophobicity, ionic composi-
tion, drug concentration, etc.) assists the analysis of the TP
microenvironment within cells.
Raman spectra of TP were excited with a wavelength of
632.8 nm, which is in preresonance with the Q absorption
band (675 nm). RR spectra of TP were recorded in the
800-1800 cm1 range because the lower frequency region
was obscured by a strong Raleigh scattering in the cellular
microspectroscopic studies. The RR spectrum of TP (Fig. 2)
contains bands related to vibrational modes of phthalocya-
nine chromophore (Table 1). The Q band is largely due to
vibronic transitions associated with the inner macrocycle
and the five-membered rings, whereas the six-membered
rings are involved only weakly (Bartholomew et al., 1989).
Accordingly, vibrational modes of the molecular moieties
related to Q-band transitions are enhanced in the RR spec-
trum. Carboxyl groups are very weakly conjugated with the
	-electron system of phthalocyanine. Thus vibrations of
carboxyl groups are not enhanced and do not contribute to
the RR spectrum of TP. The phthalocyanine vibrations are
strongly coupled, i.e., delocalized over many bonds and
atoms. Therefore the RR spectrum of TP cannot be de-
scribed in terms of characteristic bands directly related to
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vibrations of particular groups of atoms. But vibrational
mode analysis provides an estimation of the relative in-
volvement of N, N
, C, and C
 atoms in different vibra-
tions (Table 1), which may help to recognize molecular
interactions of TP that occur with the participation of these
atoms. It should be noted that the relative intensity of the
RR bands of TP depends considerably on the polarization of
the excitation light (data not shown). In the present study all
of the RR measurements were performed with nonpolarized
light from a He-Ne laser.
The TP was reported to be highly photostable in aqueous
solution (Kaliya et al., 1999). Indeed, the RR spectrum
measured with a rotated quartz cell from TP solution de-
oxygenated with nitrogen and that of one recorded with a
stationary quartz cell from TP solution saturated with oxy-
gen were found to be identical. No differences were ob-
served in RR spectra before and after prolonged (1 h)
illumination of TP solution (100 l, 10 M) with a high-
power-density laser light (20 W/cm2, 676 nm wavelength).
The exceptional photostability of the chromophore has pre-
determined the observed stability of the intracellular TP
signal in the course of microspectroscopic measurements.
Spectrophotometric analysis has shown that the absorp-
tion spectrum of TP underwent a 1-nm red shift in the
saturated solution of DNA. This shift appeared after 30 min
of incubation of the mixture at 37°C, indicating a very weak
interaction between the drug and DNA. The absorption
spectrum of TP bound to DNA calculated as described in
Materials and Methods has a 677-nm maximum. The extent
of TP binding () to DNA was estimated to be 6–8%.
Very weak interaction of TP with RNA was detected with
spectrophotometry only after 60 min of incubation of the
mixture at 37°C. Calculated absorption spectrum of TP
bound to RNA has a 696-nm maximum. The extent of TP
binding () to RNA was 4–6% under the experimental
conditions used. No noticeable changes in the RR spectra of
TP/DNA and TP/RNA mixtures as compared with that of
TP were found.
FIGURE 2 Several examples of the spectral analysis (the decomposition procedure) of RR spectra (1) recorded from within the nucleus (a), cytoplasm
(b), and lysosomes (c and d) of TP-treated cells. The decomposition of measured spectra into components was performed using a set of reference spectra
that describe TP bound to proteins (3), monomeric TP (4), and aggregated TP (5). The validity of the decomposition procedure can be estimated by
comparing an extent of coincidence of spectrum 2 simulated on the basis of components 3–5 with the experimental spectrum 1. Spectra 3–5 show the
relative contribution of each component to the overall spectrum.
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Spectrophotometric analysis has shown that TP was able
to form complexes with amino acids and bovine serum
albumin (BSA) (Kaliya et al., 1999). The ability of TP to
bind to proteins was further studied with a model set of
proteins including lysozyme, human serum albumin (HSA),
and BSA. In addition, TP interaction with the pool of
nonhistone nuclear proteins and histone H2A was investi-
gated. It was found that TP binds tightly to nonhistone
nuclear proteins, histone H2A, and lysozyme. TP formed
complexes with HSA more readily than with BSA. Interac-
tions between TP and the proteins were observed as a
12–15-nm red shift of the Q band in absorption spectra and
noticeable changes in the RR spectrum of the drug (Table
1). The values of  determined with spectrophotometry
were equal to 93%, 64%, 82%, 46%, and 86% in the cases
of HSA, BSA, histone H2A, lysozyme, and the pool of
nonhistone nuclear proteins, respectively. It is obvious that
the TP ability to bind to proteins is considerably greater than
its ability to form complexes with nucleic acids. Side chains
of many amino acid residues can participate in TP binding.
Spectrophotometric analysis shows that TP forms com-
plexes with histidine, arginine, lysine, tryptophan, and, to a
lesser degree, with phenylalanine, whereas no interactions
were detected with tyrosine or negatively charged amino
acids.
Changes in RR spectra of TP induced by interactions with
any one of the studied proteins were very similar, namely, a
moderate decrease in the relative intensities of the 1013,
1117, 1210, 1320 cm1 bands as compared to that of the
1538 cm1 band without any frequency shifts, and moder-
ate enhancement of RR cross sections of vibrational modes
(Table 1). It is obvious that TP interactions can occur via the
carboxylic groups, via the nitrogen atoms, and/or via the
cobalt atom. As was mentioned above, the carboxylic
groups are weakly conjugated with the 	-electron system of
phthalocyanine. Therefore, although their participation in
the interactions of TP with proteins may take place, it
cannot noticeably disturb the RR spectrum of TP. Bands
that undergo relative intensity changes contain a large con-
tribution from vibrational movements of the nitrogen atoms
(Table 1). Therefore it can be envisaged that interactions of
the nitrogens and/or the cobalt with external ligands are
responsible for alterations in the RR spectrum. Earlier it was
shown (Gavrilov et al., 1980; Kaliya et al., 1999) that
derivatives of cobalt (II) phthalocyanines (PcCo(II)) form
axially coordinated complexes with ligands (L) PcCo(II)Ln,
where n  1, 2, and can be further oxidized to [PcCo
(III)Ln]
. It was concluded that formation of [Pc-
Co(III)L2]
 was responsible for the changes in absorption
spectra of TP associated with amino acids and proteins
(Kaliya et al., 1999). Therefore, similar changes in RR
spectra of TP bound to different proteins can occur because
of the similar type of interactions leading to [PcCo(III)L2]

formation.
TP is not soluble in pure methanol, ethanol, or nonpolar
solvents. Absorption spectra of TP mixed with the micelles
of sodium dodecyl sulfate (SDS) or Triton X-100 are not
changed as compared to the spectrum of TP in aqueous
solution. From examination of RR spectra, no interaction
was detected between TP and detergent micelles, even at the
vibrational level. Eight negative charges situated symmet-
rically around the phthalocyanine core screen the hydropho-
bic nucleus of the molecule and exclude not only penetra-
tion into the hydrophobic region of micelles but even TP
binding at their polar surface.
It was found that the carboxylic groups make TP sensitive
to pH and divalent metal cations (Kaliya et al., 1999). A
decrease in pH from 6 to 5 induces protonation of the
carboxylic groups, followed by aggregation and precipita-
tion of TP. Ca2 cations bind to carboxylic groups, leading
to formation of an insoluble salt of TP and its precipitation.
RR spectra of monomeric and aggregated drug differ con-
siderably (Table 1). Upon aggregation the 1110, 1200,
1390, and 1430 cm1 bands undergo remarkable down-
TABLE 1 Frequencies (cm1), intensities, and assignments of vibrational modes of TP
Monomeric TP TP bound to proteins Aggregated TP
Assignments*
Involvement in vibration*†
Freq. Irel (%)‡  Freq. Irel (%)‡  Freq. Irel (%)‡ N N
 C C

1013 20 1.6 1013 6 1.4 1013 (0)§ 3 23 A2g
1117 40 3.3 1117 20 4.8 1110 (7) 20 14 B1g    
1210 90 7.3 1210 60 14.4 1200 (10) 50 13 B1g    
1320 90 7.3 1320 65 15.6 1325 (5) 40 12 B1g    
1396 40 3.2 1396 30 7.2 1390 (6)¶ 20 20 A2g
1442 20 1.6 1442 20 4.8 1430 (12)¶ 20 29 B2g
1466 30 2.4 1466 25 6.0 1464 (2)¶ 20 28 B2g
1538 100 7.9 1538 100 23.9 1544 (6) 100 3 A1g    
*The assignments were taken from previous work (Bartholomew et al., 1989).
†Relative involvement in vibration of some phthalocyanine atoms (Fig. 1): large (), medium (), small ().
‡Relative intensity of RR bands in TP spectrum at exc  632.8 nm (nonpolarized light) normalized to the 3 band.
§Frequency shift as compared with the spectrum of monomeric free TP is given in parentheses.
¶Bands in the 1380–1480 cm1 region are poorly resolved in the spectrum of aggregates.
Raman cross section of vibrational mode at the 632.8-nm excitation wavelength, in millibarns/(molecule steradian).
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frequency shifts, whereas the 1325 and 1544 cm1 bands
are shifted to higher frequencies. The frequency shifts are
accompanied by changes in relative intensities of the bands
(Table 1) and a considerable decrease in integrated intensity
of the RR signal. The RR spectrum of pH-induced aggre-
gates, the spectrum of aggregates formed in the presence of
divalent cations, and the spectrum of a polycrystalline pow-
der of the sodium salt of TP are very similar. Therefore, the
observed spectral features should be attributed to interchro-
mophore interactions within aggregates.
Molecular interactions of TP in the
presence of ascorbate
Molecular interactions of TP were studied in the presence of
ascorbate with spectrophotometry and RR spectroscopy.
Special attention was paid to the changes that could appear
in RR spectra.
In the presence of ascorbate some molecules of TP un-
dergo oxidation (Prof. S. A. Borisenko, personal communi-
cations). This is clearly observed as a time-dependent de-
crease in the absorbance of the solution at 675 nm. The
integrated intensity of the RR signal decreases in the pres-
ence of ascorbate, but RR spectra of TP do not change.
Oxidized TP does not absorb in the red region, and, there-
fore, it does not contribute to RR spectra. As a result, an
increase in the number of oxidized molecules is observed
just as a decrease in intensity of the RR spectrum.
It was found that both oxidation of TP and its action as
catalyst were abolished by TP binding to HSA (Prof. S. A.
Borisenko, personal communications). Our experiments
show that absorption and RR spectra of the studied TP/
protein complexes do not change when ascorbate is added,
thus 1) confirming that oxidation of TP bound to proteins is
reduced sharply and 2) indicating that interactions between
TP and proteins are not affected by ascorbate. Binding of TP
to the components of culture media and fetal calf serum is
also accompanied by a considerable decrease in the drug
oxidation by ascorbate. Analysis of absorption and RR
spectra indicates that the presence of ascorbate does not
enhance binding of TP to DNA or RNA.
RR spectra of TP inside living cells and
their analysis
Microspectroscopic experiments show that TP penetrates
into living A549 cells and accumulates within the cytoplasm
and nucleus. Analysis of RR spectra recorded from within
various cellular compartments indicates that, besides inte-
grated intensity, spectra are different in relative intensity
and position of bands. Using the procedure of spectral
decomposition, we revealed that intracellular spectra can be
presented as a linear combination of RR spectra of TPmono,
TPbnd, and TPagg (Fig. 2). Cellular molecules do not con-
tribute noticeably to the measured spectra because there are
no cellular chromophores that are in resonance with the
excitation used. Even the intrinsic cellular fluorescence, the
main problem for Raman microspectroscopy in the visible
region, is negligible at an excitation wavelength of 632.8
nm. Nonresonance Raman scattering of cellular molecules
is several orders less intensive than the RR signal of TP. As
a result, despite high local concentrations of cellular mole-
cules, they provide only a weak nonresolved background
contribution to the observed RR spectra.
After spectral decomposition was carried out it was
clearly seen that the RR spectrum of TP within the nucleus
is predominantly a superposition of signals of TPmono and
TPbnd (Fig. 2 a). In addition to TPmono and TPbnd the
contribution of TPagg to the overall drug spectrum is ob-
served distinctly within cytoplasmic compartments (Fig. 2
b). As is discussed below, the signal of TPagg can dominate
within lysosomes under certain conditions (Fig. 2 c). Care-
ful examination of hundreds of spectral images measured
from cells incubated with TP or TP/ascorbate mixture at
various regimes of treatment enables one to conclude that
intracellular RR spectra of the drug can be reliably de-
scribed using the set of TPmono, TPbnd, and TPagg model
spectra. In other words, three different states of the drug,
namely monomers, aggregates, and complexes with pro-
teins, can be recognized and mapped within living cells with
the CSI technique. It should be mentioned that monomeric
TP can be free or bound to cellular molecules via carboxylic
groups. The interactions occurring predominantly via car-
boxylic groups do not affect absorption and the RR spec-
trum of chromophore moiety, and therefore drug molecules
bound this way cannot be distinguished from free TP.
Localization, uptake, and retention of TP within
A549 cells
Analysis of spectral images (Figs. 3–5) clearly shows that
TP is distributed throughout the cytoplasm and accumulates
within the nucleus. The nucleus is uniformly stained with
TP. In some cells the more intense accumulation of the drug
within nucleoli than that within nucleoplasm is observed
(Figs. 3 and 5). The cytoplasmic distribution of TP is rather
diffuse after 10 min of cell incubation with the drug (Fig. 3
I). Besides uniform staining, small inclusions with highly
concentrated drug are observed in cytoplasm at incubation
times longer than 1 h (Figs. 3–5). Similar patterns of TP
intracellular accumulation and distribution were observed in
cells incubated with 400 or 100 M of the drug.
To reveal the origin of these inclusions, cells incubated
with TP were further treated with AO, the red fluorescence
of which was a label for lysosomes. Comparing an epiflu-
orescence image of the AO-marked lysosomes with a RR
confocal spectral image of TP distribution, one can note that
localization of the drug containing inclusions coincides
precisely with that of lysosomes (Fig. 6). Some lysosomes
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are not seen in the spectral image of TP. This can mean that
TP is distributed among lysosomes heterogeneously. Be-
sides, one has to keep in mind that all of the lysosomes are
detected with the epifluorescence method, whereas the CSI
technique measures the signal only from those lysosomes
that are located within a thin optical section defined by the
confocal conditions. Movement of lysosomes is another
factor that hampers the registration of precisely coincident
images of TP and lysosome distribution.
Diffused staining of cytoplasm with TP around the nu-
cleus was found to not match the filamentous pattern of
mitochondria distribution revealed with Rh123, a selective
label for active mitochondria (data not shown). Therefore it
may be deduced that there is no predominant accumulation
of TP within mitochondria.
Penetration of TP into the A549 cell is rather fast despite
the presence of eight negative charges per molecule. After
10 min of incubation the drug is already observed within the
cytoplasm and the nucleus of the cell (Figs. 3 and 7). Its
average intracellular concentration (AIC) reaches 8% of
extracellular theraphthal concentration ([TP]ext) (drug con-
centration saving aggregates is quantified). During 3 h of
cell exposure to the drug AIC grows continuously up to
30% of [TP]ext. Further intracellular accumulation of TP
becomes much slower. When the incubation time rises from
3 h to 14 h the AIC increases from 30% to 43% of [TP]ext
only (Fig. 7 a).
Distribution of TP as a whole and, singly, TPmono, TPbnd,
and TPagg among the cytoplasm and the nucleus was mea-
sured in the course of drug uptake and efflux (Figs. 3–5 and
7). Characteristic features of the kinetics of nuclear and
cytoplasm accumulation of TP are very similar to those of
AIC of the drug. At the same time the nuclear concentration
of TP is 1.5-fold higher than the cytoplasmic one during
FIGURE 3 Confocal spectral images of cells exposed to 400 M TP for 10 min (I), 1 h (II), and 14 h (III). (a) Conventional light-microscope image
of the cell. (b–e) Spectral images describing the subcellular distribution of TPagg (c), TPbnd (d), and TPmono (e), as well as total TP except for TPagg (b).
Low concentration patterns of subcellular distribution of TP are shown in column II-zoom. Scales show the concentration of TP in M for the images b,
d, and e as well as the relative intensity of signal in arbitrary units for image c. (a) Arrowheads indicate the boundary of the cell; N marks the nucleus;
the bar represents 5 m.
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uptake (Fig. 7 a). Analysis shows that this difference is
directly related to the nuclear concentration of TPbnd, which
is approximately threefold higher than the concentration of
TPbnd within cytoplasm (Fig. 7 c). TPmono is distributed
between nucleus and cytoplasm in a more equivalent man-
ner (Fig. 7 b). Pronounced accumulation of the drug within
lysosomes is observed in cells incubated with TP for 1 h and
longer (Figs. 3–5). The intralysosome concentration of TP is
five- to eightfold higher than the drug concentration in the
surrounding cytoplasm. TPmono, TPbnd, and TPagg are de-
tected within lysosomes, but TPmono dominates there. Ag-
gregation of the drug in lysosomes is enhanced as the
incubation time increases. The appearance of blue spots is
observed with the light microscope in the cytoplasm of cells
incubated with TP for 14 h (Fig. 3 IIIa). Spectral analysis
shows a very high (up to 3 mM) concentration of TP and a
considerable amount of TPagg within the lysosomes of these
cells (Fig. 3 III).
Efflux of TP in opposition to its uptake was found to be
very slow. Cells incubated with the drug for 6 h and then
grown in drug-free medium for 2 or 9 h still contained a
considerable amount of the drug (Figs. 5 and 7). Analysis
shows that AIC of TP is reduced just 1.3-fold during 9 h of
efflux. Release of drug from the nucleus and cytoplasm
occurs in a similar manner (Fig. 7). As a result, patterns of
localization and relative intracellular distribution of TPmono
and TPbnd are not changed during drug efflux (Fig. 5). A
remarkable decrease in intranuclear content of TPagg and its
increase in the cytoplasm domain (mainly within lyso-
somes) are observed (Fig. 7 d).
FIGURE 4 Confocal spectral images of cells exposed to 400 M TP (I)
and 400 M/8 mM TP/ascorbate mixture (II) for 3 h. (a) Conventional
light-microscope image of the cell. Spectral images describing the subcel-
lular distribution of TPagg (c), TPbnd (d), and TPmono (e), as well as total TP
except for TPagg (b). Scales show the concentration of TP in M for the
images b, d, and e and the relative signal intensity in arbitrary units for
image c. (a) Arrowheads indicate the boundary of the cell; N marks the
nucleus; the bar represents 5 m.
FIGURE 5 Confocal spectral images of cells exposed to 400 M TP for
6 h, immediately after the exposure period (I) and after additional incuba-
tion in drug-free medium for 9 h (II). (a) Conventional light-microscope
image of the cell. (b—e) Spectral images describing the subcellular distri-
bution of TPagg (c), TPbnd (d), and TPmono (e), as well as total TP except for
TPagg (b). Scales show the concentration of TP in M for images b, d, and
e as well as the relative intensity of signal in arbitrary units for image c. (a)
Arrowheads indicate the boundary of the cell; N marks the nucleus; the bar
represents 5 m.
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Intracellular accumulation and action of
TP/ascorbate catalytic system
Incubation of A549 cells with a TP/ascorbate mixture in-
duces inhibition of cell proliferation (Fig. 8). The control
experiment with ascorbate alone shows no noticeable cyto-
toxic action of sodium ascorbate. Incubation of cells with
TP alone reveals moderate concentration-dependent cyto-
toxicity of the agent, which is considerably lower than the
effect of the TP/ascorbate system.
To discover the critical intracellular targets of the cyto-
toxic action of the TP/ascorbate catalytic system, selective
organelle labeling was carried out. Intact A-549 cells treated
with AO show a rather homogeneous structure of the cyto-
plasmic matrix and10–100 red colored lysosomes located
mostly in close vicinity to the nucleus. A549 cells have
filamentous mitochondria radiating from the perinuclear
region, as visualized with Rh123. EtBr used as a vitality test
does not penetrate into living A549 cells. Incubation of cells
with TP or ascorbate separately does not cause any changes
in lysosome or mitochondria staining.
After 1 h of treatment with the TP/ascorbate mixture, one
can see a noticeable decrease in the amount of lysosomes.
The cytoplasmic matrix becomes rough and heterogeneous.
The distribution and activity of the mitochondria stay un-
changed. A few cells have numerous tiny blebs on the cell
membrane and orange nuclei colored with EtBr, which
indicates some disturbance of the plasma membrane
permeability.
Incubation of cells with TP/ascorbate mixture for 3 h
leads to disruption of lysosomes. Fragmentation of the fil-
amentous network of mitochondria is observed; most of
them adopt a globular shape. The CSI analysis shows that
the distribution of TP within the nucleus and the cytoplasm
becomes rather uniform (Fig. 4). Inclusions containing a
high concentration of TP are not observed in these cells,
thus confirming their assignment to lysosomes, which are
destroyed under radical attack.
Further treatment of cells with the BCS results in infla-
tion of cytoplasm, cell rounding, and cariopyknosis. Intense
blebbing of external membrane and staining of the nucleus
with EtBr now become the characteristics of many cells.
Lurid staining of the cytoplasmic matrix and nucleus with
AO can be considered to be due to the appearance of
denatured forms of nucleic acids or a decrease in cytoplas-
mic pH due to the leakage of lysosome content into the
cytoplasm.
Treatment of cells with TP/ascorbate mixture leads to a
1.5-fold decrease in AIC of the drug as compared to cells
incubated with TP alone. The decrease in TP concentration
occurs equally within the cytoplasm and nucleus of cells for
TPmono, TPbnd, and TPagg (Fig. 7) and may be related to the
destruction of TP itself during the catalysis of ascorbate
autooxidation.
DISCUSSION
The RR CSI analysis revealed that TP is distributed
throughout cytoplasm and is localized preferentially within
the nucleus of A549 cells (Figs. 3–5 and 7). A diffused
pattern of TP distribution within the nucleus is comple-
mented by slightly more intense staining of nucleoli in some
cells. Rather uniform staining of cytoplasm is accompanied
by considerable accumulation of TP within lysosomes. Mi-
tochondria do not accumulate TP. Model experiments in
solution have shown that TP has a very low ability to bind
to or to penetrate into membranous systems. Accordingly,
staining of plasmalemma or nuclear membrane with TP is
not observed. It can be concluded that TP is localized within
hydrophilic cytoplasmic domains. Nuclear localization of
TP is the main feature of the pattern of agent distribution in
the A549 human adenocarcinoma cells as compared with
that observed for TP in K562 human erythroleukemic cells
(Arzhantsev et al., 1999). This feature is probably related to
FIGURE 6 Confocal spectral images of the cell exposed to 400 M TP
for 1 h and stained after that with AO. (a) Conventional light-microscope
image of the cell. (b) Epifluorescence image corresponding to red fluores-
cence of AO. (c) Spectral image of subcellular distribution of TP. (a)
Arrowheads indicate the boundary of the cell; N marks the nucleus; the bar
represents 6 m. (b and c) Arrows indicate the lysosomes, where accu-
mulation of TP is observed. (c) Black corresponds to the highest signal
intensity.
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the origin of cells and requires further investigation, because
distinctions in the intracellular localization of TP can be a
reason for the different sensitivities of particular cancer
cells to the action of BCS.
Three states of the drug were recognized and mapped
within living cells with the CSI technique, namely TPmono,
TPbnd, and TPagg. The presence of TP bound to proteins and
aggregated TP within living cells is in accordance with the
properties of the drug observed during the study of molec-
ular interactions of TP in solution. According to the model
experiments, at least two factors can cause or assist drug
aggregation, namely protonation of carboxyl groups at low
pH and complexation with divalent cations.
Eight negative charges do not prevent TP from rapidly
penetrating A549 cells. Fluid phase pinocytosis may be the
main mechanism of uptake of hydrophilic TP. Endocytosis
also seems to be important for the internalization of TP
bound to proteins. Diffusional processes of transport of TP
into and out of the cell are considered to be rather weak,
mainly because of the large negative charge of the molecule.
This is indirectly confirmed by very low efflux of the drug
during the first period of cell incubation in drug-free me-
dium. Intracellular accumulation of TP is relatively low
compared to many other antitumor drugs. For example,
intracellular concentration of mitoxantrone achieves a 50–
80-fold excess over its extracellular concentration (Feo-
fanov et al., 1997a).
Despite low intracellular accumulation the cytotoxic ac-
tivity of the TP/ascorbate system (IC50  14 M) is on the
same order as that induced by some chemotherapy agents,
particularly cisplatin (cis-dichlorodiammine platinum (II),
IC50  26 M). It may be concluded that because of
FIGURE 7 Average intracellular (triangles), intranuclear (rhombuses), and cytoplasmic (squares) concentrations of total TP, except for TPagg (a), TPmono
(b), TPbnd (c), and TPagg (d) at different times of incubation of A549 cells with 400 M TP (open symbols) and 400 M/8 mM TP/ascorbate mixture (closed
symbols). Retention of TP in the cells incubated with 400 M TP for 6 h is shown by demiclosed symbols. Measurements of concentration have been
performed with the RR CSI technique as described in Materials and Methods.
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peculiarities of intracellular distribution of TP the TP/ascor-
bate system is efficient at inducing numerous types of
damage to subcellular organelles and cellular molecules.
Lysosome damage followed by the leakage of its contents
into the cytoplasm has been documented as one of the
primary events in the course of BCS action. This allows
these organelles to be considered one of the initial targets of
the BCS action. Disruption of mitochondrial structure was
detected, although mitochondria were not identified as a
major subcellular site of TP localization. This effect is
probably mediated by a radical attack from the cytosol
and/or is related to the leakage of lysosomal enzymes into
the cytoplasm, but it is not induced by site-directed action of
the BCS. Plasma membrane injury should be considered a
secondary effect of the BCS action, appearing only several
hours after activation of the BCS. It is in accordance with a
low affinity of the TP/ascorbate system for membranous
structures.
Preferential nuclear accumulation of TP is probably re-
sponsible for the induction of nuclear component damage.
The drug is partially bound to nuclear proteins. Both non-
histone proteins and histones form complexes with TP.
Formation of complexes between TP and histones seems to
be facilitated by electrostatic interaction of negatively
charged carboxylic groups of the drug with multiple posi-
tively charged amino acid side chains of the proteins. Bind-
ing sites of many nonhistone nuclear proteins have optimal
structures for interaction with negatively charged nucleic
acids, so TP is most probably bound within these sites.
Histones are part of the nucleosome complexes. So, more
exactly, within nucleosomes TP has to be bound to histones.
Although the tendency toward direct interaction between TP
and DNA is very slight, a high concentration and a close
proximity of the radical-generating system to DNA are
obvious. Radical-induced cleavage of DNA and oxidation
of nucleotide bases can proceed. The occurrence of these
processes in the case of the TP/ascorbate system was ob-
served in vitro (Belkov et al., 1996). It has to be mentioned
that in the case of nonhistone proteins the reduced catalytic
activity of TP bound to proteins may be overcompensated
by direct oxidation of functionally important amino acid
residues within the sites of nucleic acid binding, where TP
also seems to be bound.
It has to be mentioned that the observed weak cytotox-
icity of TP itself (Fig. 8) can also be related to the drug’s
ability to bind to nonhistone proteins. Competing to some
extent with the nucleic acids for binding to proteins of gene
machinery, TP can inhibit some of the processes of gene
regulation, transcription, etc. To clarify the types of DNA
and nuclear protein damage and their relative roles in the
overall cytotoxic effect of the TP/ascorbate system, exten-
sive additional investigations are required. Some of these
experiments are currently under way.
The BCS based on the TP/ascorbate mixture is very
promising for antitumor therapy, and it is currently at phase
I of clinical trials. Several other BCSs that were proposed
recently indicate that a binary catalytic therapy for malig-
nant tumors will be further developed. Therefore, the RR
CSI technique will be required as a unique tool applicable to
the detection of nonfluorescent transition metal complexes
within living cells. The present work is among the first to
reveal the potential of the method in this field. It demon-
strates the uses for the RR CSI technique, namely 1) reveal-
ing intracellular localization and quantitative distribution of
the catalyst among particular cellular compartments; 2)
identification of organelles selectively accumulating the
drug as potential critical targets of its action; 3) quantitative
study of kinetics of the catalyst uptake and efflux; 4) study
of intracellular state and molecular interactions of the drug
in relation to the drug activity.
As compared to the wide-field Raman imaging methods,
the RR CSI technique provides two important features: the
confocal mode of measurement and recording of the whole
spectrum at each point in the cell. The confocal regime
allows resolution and sharpness of details to be improved in
Raman images through the suppression of signals from
specimen layers above and below the scanning optical sec-
tion. But, what is more important, it is a basis for quantita-
tive measurements. The thickness of the scanning layer is
fixed during all of the measurements, and it is less than the
thickness of the cell. So the intensity of a spectrum is
proportional to the intracellular concentration of the drug.
By using a calibration procedure described in Materials and
Methods, researchers can perform quantitative analysis.
FIGURE 8 Concentration-response curves for survival of A549 cells
after exposure to TP (open circles), ascorbate (closed squares), and TP/
ascorbate mixture at molar ratio 1/20 (open triangles). The ordinate is the
survival of tumor cells expressed as a percentage of control. Abscissa: The
upper axis is the concentration of ascorbate (closed symbols); the lower
axis is the concentration of TP (open symbols). For details see Materials
and Methods.
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Spectral analysis allows different states and molecular
interactions of the drug to be reliably identified and mapped
within living cells. This advantage of the RR CSI technique
can be well illustrated, using TP as an example. It is not
possible to indicate particular well-resolved Raman bands
corresponding to TPmono, TPbnd, or TPagg only and to use
them for image measurement with the filtering Raman im-
aging methods. The whole spectrum should be analyzed
with the spectral decomposition procedure to characterize
the state of the drug at each point in a cell.
Beside living cells it is quite important to understand the
peculiarities of accumulation and localization of catalytic
component of BCSs within malignant tissues. To do this the
RR CSI approach can be applied to analyze cryogenic tissue
sections and biopsy probes from patients. Thus the RR CSI
study of distribution and interaction of TP within tissue
structures is in progress now.
We are indebted to L. G. Nikolaev for a gift of extract of nonhistone
nuclear proteins and fruitful discussions. We thank Dr. V. L. Karpov for a
gift of histone H2A. We are grateful to Prof. O. L. Kaliya and E. A.
Lukyanets for a gift of theraphthal sample and useful discussions.
This research was supported by a grant from Moscow anticancer program.
AIG was supported by the FEBS Summer Fellowship. AVF was supported
by the FEBS Short Term Fellowship.
REFERENCES
Arzhantsev, S. Y., A. Y. Chikishev, N. I. Koroteev, J. Greve, C. Otto, and
N. M. Sijtsema. 1999. Localization study of Co-phthalocyanines in cells
by Raman micro(spectro)scopy. J. Raman Spectrosc. 30:205–208.
Bartholomew, C. R., A. A. McConnel, and W. E. Smith. 1989. Resonance
Raman excitation profile of cobalt phthalocyanine at room temperature
and 10 K. J. Raman Spectrosc. 20:595–600.
Carmichael, J., W. G. DeGraff, A. F. Gazdar, J. D. Minna, and J. B.
Mitchell. 1987. Evaluation of a tetrazolium-based semiautomated col-
orimetric assay: assessment of chemosensitivity testing. Cancer Res.
47:936–942.
Belkov, V. M., N. F. Krynetskaya, Z. A. Shabarova, G. N. Novodarova,
and M. E. Vol’pin. 1996. Transition-metal complexes as catalysts of
active oxygen species formation in autooxidation reactions. 2. Oxidative
degradation of nucleic acids by cobalt and iron phthalocyanine com-
plexes. Russ. Chem. Bull. 45:2105–2111.
Bubnovskaya, L. N., M. E. Vol’pin, I. I. Ganusevich, I. Ya. Levitin, V. K.
Onanezov, S. P. Osinsky, A. A. Pankratov, A. L. Sigan, V. V. Surgai,
M. V. Tsikalova, and R. I. Iakubovskaya. 1998. Shiff-based Co-
complexes as potent antitumor agents and anticancer therapy modifiers.
Mendeleev Chem. J. 42:128–140.
Cameron, E., L. Pauling, and B. Leibovitz. Ascorbic acid and cancer: a
review. 1979. Cancer Res. 39:663–681.
Clark, R. J. H., and R. E. Hester. 1993. Advances in Spectroscopy, Vol. 20,
Biomolecular Spectroscopy, Part A. Wiley, Chichester, England.
Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate tran-
scription initiation by RNA polymerase II in a soluble extract from
isolated mammalian nuclei. Nucleic Acid Res. 11:1475–1489.
Favard, C., P. Valisa, M. Egret-Charlier, S. Sharonov, C. Herben, M.
Manfait, E. Da Silva, and P. Vigny. 1999. A new UV-visible confocal
laser scanning microspectrofluorometer designed for spectral cellular
imaging. Biospectroscopy. 5:101–115.
Feofanov, A., S. Charonov, F. Fleury, I. Kudelina, and I. Nabiev. 1997a.
Quantitative confocal spectral imaging analysis of mitoxantrone within
living K562 cells: intracellular accumulation and distribution of mono-
mers, aggregates, naphtoquinoxaline metabolite and drug-target com-
plexes. Biophys. J. 73:3328–3336.
Feofanov, A., S. Charonov, I. Kudelina, F. Fleury, and I. Nabiev. 1997b.
Localization and molecular interactions of mitoxantrone within living
K562 cells as probed by confocal spectral imaging analysis. Biophys. J.
73:3317–3327.
Feofanov, A., S. Sharonov, P. Valisa, E. Da Silva, I. Nabiev, and M.
Manfait. 1995. A new confocal stigmatic spectrometer for micro-Raman
and microfluorescence spectral imaging analysis: design and applica-
tions. Rev. Sci. Instrum. 66:3146–3158.
Fodor, S. P. A., R. A. Copeland, C. A. Grygon, and T. G. Spiro. 1989.
Deep-ultraviolet Raman excitation profiles and vibronic scattering
mechanisms of phenylalanine, tyrosine, and tryptophan. J. Am. Chem.
Soc. 111:5509–5518.
Gavrilov, V. I., L. G. Tomilova, E. V. Chernih, O. L. Kaliya, I. V.
Shelepin, and E. A. Lukyanets. 1980. Charge migration in products of
single electron oxidation of cobalt phthalocyanine. Zh. Obshch. Khim.
(Russ.). 50:2143–2144.
Greve, J., and G. J. Puppels. 1993. Advances in Spectroscopy, Vol. 20,
Biomolecular Spectroscopy, Part A. R. J. H. Clark and R. E. Hester,
editors. Wiley, Chichester, England. 231–265.
Halliwell, B., and C. H. Foyer. 1976. Ascorbic acid, metal ions and the
superoxide radical. Biochem. J. 155:697–700.
Honegger, C. G., J. Torhorst, H. Langemann, A. Kabiersch, and W.
Krenger. 1988. Quantitative determination of water-soluble scavengers
in neoplastic and non-neoplastic human breast tissue. Int. J. Cancer.
15:690–694.
Kaliya, O. L., N. V. Teplyakova, Eu. A. Lukyanets, and G. N. Vorozhtsov.
1999. Study of physical-chemical properties and molecular interactions
of cobalt (II) octa-4,5-carboxyphthalocyanine. J. Porphyrins Phthalo-
cyanines. (in press).
Kimoto, E., H. Tanaka, J. Gyotoku, F. Morishige, and L. Pauling. 1983.
Enhancement of antitumor activity of ascorbate against Ehrlich ascites
tumor cells by the copper:glycylglycylhistidine complex. Cancer Res.
43:824–828.
Liu, K., L. Chen, R. Sheng, and M. D. Morris. 1991. Multispectral
Hadamard-transform Raman microscopy. Appl. Spectrosc. 45:
1717–1720.
Pierson, H. F., J. M. Fisher, and M. Rabinovitz. 1985. Depletion of
extracellular cysteine with hydroxocobalamin and ascorbate in experi-
mental murine cancer chemotherapy. Cancer Res. 45:4727–4731.
Poydock, M. E. 1991. Effect of combined ascorbic acid and B-12 on
survival of mice with implanted Ehrlich carcinoma and L1210-leukemia.
Am. J. Clin. Nutr. 54:1261–1265.
Puppels, G. J., and J. Greve. 1996. Advances in Spectroscopy, Vol. 25,
Biomedical Applications of Spectroscopy. R. J. H. Clark and R. E.
Hester, editors. Wiley, Chichester, England. 1–47.
Puppels, G. J., M. Grond, and J. Greve. 1993. Direct imaging Raman
microscopy based on tunable wavelength excitation and narrow band
emission detection. Appl. Spectrosc. 47:1256–1267.
Sharonov, S., I. Chourpa, H. Morjani, I. Nabiev, M. Manfait, and A.
Feofanov. 1994a. Confocal spectral imaging analysis in studies of the
spatial distribution of antitumor drugs within living cancer cells. Anal.
Chim. Acta. 290:40–47.
Sharonov, S., I. Nabiev, I. Chourpa, A. Feofanov, P. Valisa, and M.
Manfait. 1994b. Confocal three-dimensional scanning laser Raman-
SERS-fluorescence microprobe. Spectral imaging and high resolution
applications. J. Raman Spectrosc. 25:699–707.
Sijtsema, N. M., S. D. Wouters, C. J. de Grauw, C. Otto, and J. Greve.
1998. Confocal direct imaging Raman microscope: design and applica-
tions in biology. Appl. Spectrosc. 52:348–355.
Syrkin, A. B., O. S. Zhukova, B. S. Kikot, L. G. Gatinskaya, E. M.
Treshalina, R. I. Yakubovskaya, A. A. Pankratov, L. M. Mikhaylova,
N. I. Zimakova, E. Yu. Kolesnikova, N. A. Oborotova, A. P. Polozkova,
G. K. Gerasimova, O. L. Kaliya, S. G. Kuz’min, E. A. Luk’yanets, G. N.
Vorozhtsov, and N. N. Trapeznikov. 1998. Theraphthal—new agent for
binary catalytic therapy of malignant tumors. Mendeleev Chem. J. 42.5:
140–146.
Raman Imaging Study of Theraphthal 511
Biophysical Journal 78(1) 500–513
Treado, P. J., I. W. Levin, and E. N. Lewis. 1992. Near-infrared acous-
tooptic filtered spectroscopic microscopy—a solid state approach to
chemical imaging. Appl. Spectrosc. 46:553–559.
Treado, P. J., and M. D. Morris. 1990. Multichannel Hadamard-transform
Raman microscopy. Appl. Spectrosc. 44:1–4.
Vol’pin, M. E., N. Yu. Krainova, I. Ya. Levitin, Z. Ya. Mitiaeva, G. N.
Novodarova, V. K. Onanezov, A. A. Pankratov, V. I. Chissov, and R. I.
Yakubovskaya. 1998. B12 compounds in combination with ascorbic acid
as potential antitumor agents. Mendeleev Chem. J. 42.5:116–127.
Vol’pin, M. E., N. Yu. Krainova, I. V. Moskaleva, G. N. Novodarova,
G. N. Vorozhtsov, M. G. Gal’pern, O. L. Kaliya, E. A. Luk’yanets, and
S. A. Mikhalenko. 1996. Transition-metal complexes as catalysts of
active oxygen species formation in autooxidation reactions. 1. Cobalt
and iron phthalocyanine complexes. Russ. Chem. Bull. 45.8:2105–2111.
Vol’pin, M. E., G. N. Vorozhtsov, G. K. Gerasimova, O. S. Zhukova, N. I.
Kazachkina, O. L. Kaliya, N. Yu. Krainova, I. Ya. Levitin, Yu. M.
Luzhkov, E. A. Luk’yanets, G. N. Novodarova, E. M. Treshalina, A. B.
Syrkin, V. I. Chissov, and R. I. Yakubovskaya. 1995. Agent for sup-
pressing tumor growth. Patent PCT Int. Appl. WO 97 03,666. (Cl.
A61K31/40), 6 Feb. 1997. RU, Appl. 95,112,240, 17 Jul; 16 pp. (Russ).
Williams, K. P. J., G. D. Pitt, B. J. E. Smith, A. Whitley, D. N. Batchelder,
and I. P. Hayward. 1994. Use of a rapid-scanning stigmatic Raman
imaging spectrograph in the industrial environment. J. Raman Spectrosc.
25:131–138.
512 Feofanov et al.
Biophysical Journal 78(1) 500–513
